Cargando…

The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia

Schizophrenia is a complex and incompletely elucidated pathology that affects sensorimotor function and also produces numerous therapeutic challenges. The aims of this cross-sectional study were to identify the profile of neurological soft signs (NSS) in patients with predominantly negative symptoms...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrescu, Cristian, Papacocea, Ioana R., Vilciu, Crisanda, Mihalache, Oana A., Vlad, Diana M., Marian, Gabriela, Focseneanu, Brindusa E., Sima, Cristian T., Ciobanu, Constantin A., Riga, Sorin, Ciobanu, Adela M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687986/
https://www.ncbi.nlm.nih.gov/pubmed/36428507
http://dx.doi.org/10.3390/biomedicines10112939
_version_ 1784836152018075648
author Petrescu, Cristian
Papacocea, Ioana R.
Vilciu, Crisanda
Mihalache, Oana A.
Vlad, Diana M.
Marian, Gabriela
Focseneanu, Brindusa E.
Sima, Cristian T.
Ciobanu, Constantin A.
Riga, Sorin
Ciobanu, Adela M.
author_facet Petrescu, Cristian
Papacocea, Ioana R.
Vilciu, Crisanda
Mihalache, Oana A.
Vlad, Diana M.
Marian, Gabriela
Focseneanu, Brindusa E.
Sima, Cristian T.
Ciobanu, Constantin A.
Riga, Sorin
Ciobanu, Adela M.
author_sort Petrescu, Cristian
collection PubMed
description Schizophrenia is a complex and incompletely elucidated pathology that affects sensorimotor function and also produces numerous therapeutic challenges. The aims of this cross-sectional study were to identify the profile of neurological soft signs (NSS) in patients with predominantly negative symptoms of schizophrenia (PNS) compared with patients with schizophrenia who do not present a predominance of negative symptoms (NPNS) and also to objectify the impact of treatment on the neurological function of these patients. Ninety-nine (n = 99; 56 females and 43 males) patients diagnosed with schizophrenia according to DSM-V were included; these patients were undergoing antipsychotic (4 typical antipsychotics, 86 atypical antipsychotics, and 9 combinations of two atypical antipsychotics) or anticholinergic treatment (24 out of 99) at the time of evaluation, and the PANSS was used to identify the patients with predominantly negative symptoms (n = 39), the Neurological Evaluation Scale (NES) was used for the evaluation of neurological soft signs (NSS), and the SAS was used for the objectification of the extrapyramidal side effects induced by the neuroleptic treatment, which was converted to chlorpromazine equivalents (CPZE). The study’s main finding was that, although the daily dose of CPZE did not represent a statistically significant variable, in terms of neurological soft signs, patients with PNS had higher rates of NSS.
format Online
Article
Text
id pubmed-9687986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96879862022-11-25 The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia Petrescu, Cristian Papacocea, Ioana R. Vilciu, Crisanda Mihalache, Oana A. Vlad, Diana M. Marian, Gabriela Focseneanu, Brindusa E. Sima, Cristian T. Ciobanu, Constantin A. Riga, Sorin Ciobanu, Adela M. Biomedicines Article Schizophrenia is a complex and incompletely elucidated pathology that affects sensorimotor function and also produces numerous therapeutic challenges. The aims of this cross-sectional study were to identify the profile of neurological soft signs (NSS) in patients with predominantly negative symptoms of schizophrenia (PNS) compared with patients with schizophrenia who do not present a predominance of negative symptoms (NPNS) and also to objectify the impact of treatment on the neurological function of these patients. Ninety-nine (n = 99; 56 females and 43 males) patients diagnosed with schizophrenia according to DSM-V were included; these patients were undergoing antipsychotic (4 typical antipsychotics, 86 atypical antipsychotics, and 9 combinations of two atypical antipsychotics) or anticholinergic treatment (24 out of 99) at the time of evaluation, and the PANSS was used to identify the patients with predominantly negative symptoms (n = 39), the Neurological Evaluation Scale (NES) was used for the evaluation of neurological soft signs (NSS), and the SAS was used for the objectification of the extrapyramidal side effects induced by the neuroleptic treatment, which was converted to chlorpromazine equivalents (CPZE). The study’s main finding was that, although the daily dose of CPZE did not represent a statistically significant variable, in terms of neurological soft signs, patients with PNS had higher rates of NSS. MDPI 2022-11-15 /pmc/articles/PMC9687986/ /pubmed/36428507 http://dx.doi.org/10.3390/biomedicines10112939 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Petrescu, Cristian
Papacocea, Ioana R.
Vilciu, Crisanda
Mihalache, Oana A.
Vlad, Diana M.
Marian, Gabriela
Focseneanu, Brindusa E.
Sima, Cristian T.
Ciobanu, Constantin A.
Riga, Sorin
Ciobanu, Adela M.
The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
title The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
title_full The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
title_fullStr The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
title_full_unstemmed The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
title_short The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
title_sort impact of antipsychotic treatment on neurological soft signs in patients with predominantly negative symptoms of schizophrenia
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687986/
https://www.ncbi.nlm.nih.gov/pubmed/36428507
http://dx.doi.org/10.3390/biomedicines10112939
work_keys_str_mv AT petrescucristian theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT papacoceaioanar theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT vilciucrisanda theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT mihalacheoanaa theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT vladdianam theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT mariangabriela theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT focseneanubrindusae theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT simacristiant theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT ciobanuconstantina theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT rigasorin theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT ciobanuadelam theimpactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT petrescucristian impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT papacoceaioanar impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT vilciucrisanda impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT mihalacheoanaa impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT vladdianam impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT mariangabriela impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT focseneanubrindusae impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT simacristiant impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT ciobanuconstantina impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT rigasorin impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia
AT ciobanuadelam impactofantipsychotictreatmentonneurologicalsoftsignsinpatientswithpredominantlynegativesymptomsofschizophrenia